MX9703194A - Methods for the diagnosis of glaucoma. - Google Patents

Methods for the diagnosis of glaucoma.

Info

Publication number
MX9703194A
MX9703194A MX9703194A MX9703194A MX9703194A MX 9703194 A MX9703194 A MX 9703194A MX 9703194 A MX9703194 A MX 9703194A MX 9703194 A MX9703194 A MX 9703194A MX 9703194 A MX9703194 A MX 9703194A
Authority
MX
Mexico
Prior art keywords
glaucoma
tigr
diagnosis
methods
protein
Prior art date
Application number
MX9703194A
Other languages
Spanish (es)
Other versions
MXPA97003194A (en
Inventor
Thai D Nguyen
Jon R Polansky
Weidong Huang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX9703194A publication Critical patent/MX9703194A/en
Publication of MXPA97003194A publication Critical patent/MXPA97003194A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/168—Glaucoma

Abstract

A glucocorticoid-induced protein, TIGR, that is produced by cells of the trabecular meshwork can be used to diagnose glaucoma. The TIGR protein, anti-TIGR antibodies, and TIGR encoding sequences also provide a diagnostic for glaucoma and its related diseases.
MXPA/A/1997/003194A 1994-11-03 1997-04-30 Methods for the diagnosis of glauc MXPA97003194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08336235 1994-11-03
US08/336,235 US5606043A (en) 1994-11-03 1994-11-03 Methods for the diagnosis of glaucoma
PCT/US1995/014024 WO1996014411A1 (en) 1994-11-03 1995-10-27 Methods for the diagnosis of glaucoma

Publications (2)

Publication Number Publication Date
MX9703194A true MX9703194A (en) 1997-07-31
MXPA97003194A MXPA97003194A (en) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
NZ297601A (en) 1999-04-29
JP4099829B2 (en) 2008-06-11
DE69535214D1 (en) 2006-10-19
AU705420B2 (en) 1999-05-20
CA2204375A1 (en) 1996-05-17
US6248867B1 (en) 2001-06-19
ATE338818T1 (en) 2006-09-15
NO972024L (en) 1997-07-02
WO1996014411A1 (en) 1996-05-17
US5861497A (en) 1999-01-19
EP0789762A1 (en) 1997-08-20
WO1998044107A1 (en) 1998-10-08
NO972024D0 (en) 1997-04-30
NO323252B1 (en) 2007-02-12
MY134914A (en) 2007-12-31
ZA959256B (en) 1996-08-14
AU2432897A (en) 1998-10-22
CA2204375C (en) 2006-04-11
EP0789762B1 (en) 2006-09-06
AU4279296A (en) 1996-05-31
DE69535214T2 (en) 2007-08-02
JPH10509866A (en) 1998-09-29
US5606043A (en) 1997-02-25

Similar Documents

Publication Publication Date Title
ZA959256B (en) Methods for the diagnosis of glaucoma
EP0378924A3 (en) Detection of neurological disease or dysfunction
HK1011697A1 (en) Monoclonal antibody active against cd44v6
DE69103623T2 (en) STEROID CUFF ELECTRODE FOR STIMULATION OF A PERIPHERAL NERVE.
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
CA2133106A1 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
PL309637A1 (en) Diagnostic test and therapy for demyelination diseases such as multiple sclerosis
BR9509317A (en) Interleukin-1 antagonist
IT1239719B (en) USE OF THE SP-2 MONOCLONAL ANTIBODY IN CLINICAL DIAGNOSTICS AND THE MONITORING OF THE PROGRESS OF HIV INFECTION
AU2087495A (en) Means for treating autoimmune diseases and a method for the treatment thereof
MX9606108A (en) MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
ATE84069T1 (en) MURINE HYBRIDOMA LYM-2 AND DIAGNOSTIC ANTIBODY PRODUCED BY IT.
Nittel et al. Diagnosing Rates of Wear by Using Scanning Electron Microscopy
AU4800890A (en) Method to diagnose and treat amyloidoses specifically and substance therefor
RU96108512A (en) METHOD FOR DIAGNOSTIC OF ENTEROVIRAL UVEITS IN CHILDREN AT LONG TIME
UA29101A (en) The method for diagnostics of child heart little structure abnormalities